Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Aronson

Showing results (271-280 of 572) with videos related to

Pageof 58
Sort By:
Transplantation|February 1, 1987
OKT3 treatment of steroid-resistant renal allograft rejectionJ R Thistlethwaite, A O Gaber, B W Haag, et al.
BJU International|June 25, 2009
Does early prostate-specific antigen doubling time (ePSADT) after radical prostatectomy, calculated using PSA values from the first detectable until the first recurrence value, correlate with standard PSADT? A report from the Shared Equal Access Regional Cancer Hospital Database GroupAnna E Teeter, Joseph C Presti, William J Aronson, et al.
European Urology|December 19, 2012
Detectable prostate-specific antigen Nadir during androgen-deprivation therapy predicts adverse prostate cancer-specific outcomes: results from the SEARCH databaseChristopher J Keto, William J Aronson, Martha K Terris, et al.
Urology|June 29, 2013
Do nomograms designed to predict biochemical recurrence (BCR) do a better job of predicting more clinically relevant prostate cancer outcomes than BCR? A report from the SEARCH database groupAnna E Teeter, Joseph C Presti, William J Aronson, et al.
Epigenetics|November 26, 2021
Exploring the impact of night shift work on methylation of circadian genesJennifer A Ritonja, Kristan J Aronson, Lisa Flaten, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 8, 2019
Shift Work Patterns, Chronotype, and Epithelial Ovarian Cancer RiskLisa Leung, Anne Grundy, Jack Siemiatycki, et al.
Human Pathology|April 1, 1982
IgA nephropathy: morphologic predictors of progressive renal diseaseS M Lee, V M Rao, W A Franklin, et al.
Urology|October 13, 2009
Freedom from a detectable ultrasensitive prostate-specific antigen at two years after radical prostatectomy predicts a favorable clinical outcome: analysis of the SEARCH databaseSteven L Chang, Stephen J Freedland, Martha K Terris, et al.
The Journal of Urology|November 7, 2006
Is biopsy Gleason score independently associated with biochemical progression following radical prostatectomy after adjusting for pathological Gleason score?Nicholas J Fitzsimons, Joseph C Presti, Christopher J Kane, et al.
BJU International|March 21, 2009
Exposure to Agent Orange is a significant predictor of prostate-specific antigen (PSA)-based recurrence and a rapid PSA doubling time after radical prostatectomySagar R Shah, Stephen J Freedland, William J Aronson, et al.
Pageof 58

Showing results (271-280 of 572) with videos related to

Sort By:
Pageof 58
Transplantation|February 1, 1987
OKT3 treatment of steroid-resistant renal allograft rejectionJ R Thistlethwaite, A O Gaber, B W Haag, et al.
BJU International|June 25, 2009
Does early prostate-specific antigen doubling time (ePSADT) after radical prostatectomy, calculated using PSA values from the first detectable until the first recurrence value, correlate with standard PSADT? A report from the Shared Equal Access Regional Cancer Hospital Database GroupAnna E Teeter, Joseph C Presti, William J Aronson, et al.
European Urology|December 19, 2012
Detectable prostate-specific antigen Nadir during androgen-deprivation therapy predicts adverse prostate cancer-specific outcomes: results from the SEARCH databaseChristopher J Keto, William J Aronson, Martha K Terris, et al.
Urology|June 29, 2013
Do nomograms designed to predict biochemical recurrence (BCR) do a better job of predicting more clinically relevant prostate cancer outcomes than BCR? A report from the SEARCH database groupAnna E Teeter, Joseph C Presti, William J Aronson, et al.
Epigenetics|November 26, 2021
Exploring the impact of night shift work on methylation of circadian genesJennifer A Ritonja, Kristan J Aronson, Lisa Flaten, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 8, 2019
Shift Work Patterns, Chronotype, and Epithelial Ovarian Cancer RiskLisa Leung, Anne Grundy, Jack Siemiatycki, et al.
Human Pathology|April 1, 1982
IgA nephropathy: morphologic predictors of progressive renal diseaseS M Lee, V M Rao, W A Franklin, et al.
Urology|October 13, 2009
Freedom from a detectable ultrasensitive prostate-specific antigen at two years after radical prostatectomy predicts a favorable clinical outcome: analysis of the SEARCH databaseSteven L Chang, Stephen J Freedland, Martha K Terris, et al.
The Journal of Urology|November 7, 2006
Is biopsy Gleason score independently associated with biochemical progression following radical prostatectomy after adjusting for pathological Gleason score?Nicholas J Fitzsimons, Joseph C Presti, Christopher J Kane, et al.
BJU International|March 21, 2009
Exposure to Agent Orange is a significant predictor of prostate-specific antigen (PSA)-based recurrence and a rapid PSA doubling time after radical prostatectomySagar R Shah, Stephen J Freedland, William J Aronson, et al.
Pageof 58